FindTrial
Sign In

Pathological analysis and significance of the comparisons between core needle biopsy and general pathology for breast tissues

Pathological analysis and significance of the comparisons between core needle biopsy and general pathology for breast tissues

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017285
Enrollment
Unknown
Registered
2018-07-21
Start date
2006-01-01
Completion date
Unknown
Last updated
2018-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

neoadjuvant:neoadjuvant
non-neoadjuvant:non-neoadjuvant

Sponsors

Tongzhou Maternal and Child Health Hospital of Beijing
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
27 Years to 73 Years

Inclusion criteria

Inclusion criteria: patients with primary breast cancer

Exclusion criteria

Exclusion criteria: patients had other cancers, and/or during in the perinatal period

Design outcomes

Primary

MeasureTime frame
histological grading;—

Countries

China

Contacts

Public ContactChunjie Sun

Tongzhou Maternal and Child Health Hospital of Beijing

wfwlgq1@163.com+86 14763482294

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026